These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
182 related articles for article (PubMed ID: 5131655)
1. [Chologonic and choleretic action of the Soviet preparation xylite]. Grancharov VP Vopr Pitan; 1971; 30(6):18-20. PubMed ID: 5131655 [No Abstract] [Full Text] [Related]
2. [Effect of xylite on hepatic and pancreatic function in biliary pathology]. Rafes IuI; Sheleketina II; Voroteliak VS; Kulikova ZS; Mel'nichenko LIa Vrach Delo; 1972 Feb; 2():10-4. PubMed ID: 5084716 [No Abstract] [Full Text] [Related]
3. [Choleretic effect of Bulgarian rose oil]. Tashev TA; Belousov AS; Gryneharov VP; Zhigalova MF Klin Med (Mosk); 1970 Aug; 48(8):57-61. PubMed ID: 5476044 [No Abstract] [Full Text] [Related]
4. [Xylitol as a choleretic and cholecystokinetic agent]. Gruncharov V Vutr Boles; 1973; 12(2):69-73. PubMed ID: 4713058 [No Abstract] [Full Text] [Related]
5. [Assessment of the cholagogic effect of sunflower seed oil and magnesium sulfate on the basis of the urocholecystokinin level]. Popova EA; Gol'tiakova TV Sov Med; 1969 Apr; 32(4):57-62. PubMed ID: 5378880 [No Abstract] [Full Text] [Related]
6. [Trial and evaluation of a new hepatoprotector, choleretic and antispasmodic preparation]. Fernández Navarro MD; García Pérez M; Arias Vallejo E Rev Esp Enferm Apar Dig; 1972 Oct; 38(4):503-10. PubMed ID: 4629092 [No Abstract] [Full Text] [Related]
7. [Controlled double-blind clinical study of cinnametic acid, a new choleretic agent in hepatobiliary diseases]. Marchettini G; Maggi P; Benvenuti C Clin Ter; 1978 Sep; 86(5):485-94. PubMed ID: 367683 [No Abstract] [Full Text] [Related]
9. [Odeston in treatment of chronic diseases of hepatobiliary system]. Nasonova SV; Lebedeva OI Voen Med Zh; 2001 Feb; 322(2):49-53. PubMed ID: 11338822 [No Abstract] [Full Text] [Related]
10. [Amphocholeretic effect of Fumaria officinalis]. Fiegel G Z Allgemeinmed; 1971 Dec; 47(34):1819-20. PubMed ID: 5134143 [No Abstract] [Full Text] [Related]
11. [Clinical trial of an hepatobiliary analeptic agent]. Chapuy H; Jeune M; Sambin P; Girard M J Med Lyon; 1971 Jun; 52(211):1025-34. PubMed ID: 5138331 [No Abstract] [Full Text] [Related]
12. [A new choleretic mixture (hydro- and cytocholeretic)]. Boisson J; Albot G Actual Hepatogastroenterol (Paris); 1966; 2(4):XXIX-XXXI. PubMed ID: 5983695 [No Abstract] [Full Text] [Related]
13. [The characteristics of the use of ursodeoxycholic acid in chronic diseases of the hepatobiliary system]. Dehtiar'ova II; Chernenko VV; Anokhina HA; Opanasiuk ND; Pavlik-Novol's'kyĭ T; Haĭsenko AV Lik Sprava; 1995; (9-12):47-8. PubMed ID: 8983789 [No Abstract] [Full Text] [Related]
14. [Current status of hepatic and biliary drug therapy. Part I]. Donatelli L; Marmo E Clin Ter; 1976 Mar; 76(5):395-409. PubMed ID: 791566 [No Abstract] [Full Text] [Related]
16. [Imecromone: a new choleretic with antispastic action on Oddi's sphincter. Clinical pharmacology and clinico-statistical study]. Cremoncini C; Tominz L Minerva Med; 1968 Oct; 59(82):4359-68. PubMed ID: 5683717 [No Abstract] [Full Text] [Related]
17. [Treatment of chronic inflammatory diseases of the biliary tract in children with the new choleretic drug Stachyren]. Shmorgun SS; Zinchenko TV; Kuz'menko IA Farm Zh; 1971; 26(6):48-50. PubMed ID: 5150543 [No Abstract] [Full Text] [Related]
18. [Indications and contraindications of choleretic therapy]. Grossi F Clin Ter; 1974; 70(2):108-9. PubMed ID: 4409826 [No Abstract] [Full Text] [Related]
19. [Hepatobiliary lesions in Crohn's disease and conservative methods of treatment]. Grigor'eva GA; Meshalkina NIu Eksp Klin Gastroenterol; 2013; (6):3-6. PubMed ID: 24772851 [No Abstract] [Full Text] [Related]
20. [The chologenic and choleretic action of sorbitol]. Grancharov V Vopr Pitan; 1973; 32(2):50-4. PubMed ID: 4782923 [No Abstract] [Full Text] [Related] [Next] [New Search]